# Justification & Approval for Sole Source: Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs)

Canonical: https://abierto.us/opportunities/75f40124q122639ja

- Solicitation number: 75F40124Q122639J-A
- Notice type: Special notice
- Status: Closed. Deadline was March 25, 2024 at 11:00 AM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: 6505 Drugs and Biologicals
- First posted: March 19, 2024
- Last posted: March 19, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/d94e793dfb1a4759b1dba1362f42e097/view

## Description

See J&A for Sole Source procurement for Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs). See also associated Intent to Sole Source and RFQ under notice #: 75F40124Q122639

## Publications

- March 19, 2024: Special notice, due March 25, 2024 at 11:00 AM EDT. Notice d94e793dfb1a4759b1dba1362f42e097. https://sam.gov/workspace/contract/opp/d94e793dfb1a4759b1dba1362f42e097/view

## Points of contact

- Suzanne Martella, suzanne.martella@fda.hhs.gov, 8705437540

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124q122639ja.